Brian K. Link
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment 219
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research 100
- Oncology top 0.2%
- Viral-associated cancers and disorders 55
- CAR-T cell therapy research 25
- Immunology top 0.5%
-
- Monoclonal and Polyclonal Antibodies Research 33
-
- CNS Lymphoma Diagnosis and Treatment 26
-
- Lung Cancer Treatments and Mutations 20
-
- Ovarian cancer diagnosis and treatment 20
- Co-authors
- James R. CerhanMatthew J. MaurerRonald LevyChristine A. WhiteA.J. Grillo-LópezPeter McLaughlinM. S. CzuczmanGeorge J. Weiner
- Journals
- Blood (87 papers)Journal of Clinical Oncology (46 papers)American Journal of Hematology (14 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Brian K. Link
262 papers receiving 11.0k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Pathology and Forensic Medicine 7.3k
- Genetics 3.5k
- Oncology 5.6k
- Immunology 2.8k
- Radiology, Nuclear Medicine and Imaging 2.3k
Countries citing papers authored by Brian K. Link
This map shows the geographic impact of Brian K. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian K. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian K. Link more than expected).
Fields of papers citing papers by Brian K. Link
This network shows the impact of papers produced by Brian K. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian K. Link. The network helps show where Brian K. Link may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brian K. Link, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 12 | |
| 2 | 2022 | 7 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 13 | |
| 5 | 2021 | 21 | |
| 6 | 2021 | 6 | |
| 7 | 2020 | 3 | |
| 8 | 2019 | 88 | |
| 9 | 2019 | 22 | |
| 10 | 2019 | 20 | |
| 11 | 2019 | 38 | |
| 12 | 2018 | 1 | |
| 13 | Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 studybreakdown → | 2017 | 1042 |
| 14 | 2016 | 13 | |
| 15 | Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Studybreakdown → | 2015 | 509 |
| 16 | 2013 | 12 | |
| 17 | 2012 | 54 | |
| 18 | 2010 | 104 | |
| 19 | 2009 | 66 | |
| 20 | 2005 | 199 |
About Brian K. Link
Brian K. Link is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Reproductive Medicine and Dermatology, having authored 275 papers that have together received 11.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (219 papers), Chronic Lymphocytic Leukemia Research (100 papers), Viral-associated cancers and disorders (55 papers), Monoclonal and Polyclonal Antibodies Research (33 papers), CNS Lymphoma Diagnosis and Treatment (26 papers), CAR-T cell therapy research (25 papers), Lung Cancer Treatments and Mutations (20 papers) and Ovarian cancer diagnosis and treatment (20 papers). The work is most often cited by research in Pathology and Forensic Medicine (7.3k citations), Genetics (3.5k citations), Oncology (5.6k citations), Immunology (2.8k citations) and Radiology, Nuclear Medicine and Imaging (2.3k citations). Brian K. Link has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include James R. Cerhan, Matthew J. Maurer, Ronald Levy, Christine A. White, A.J. Grillo-López, Peter McLaughlin, M. S. Czuczman, George J. Weiner, Michael E. Williams and B.K. Dallaire. Their work appears in journals such as Blood, Journal of Clinical Oncology, American Journal of Hematology, Blood Advances and Blood Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.